FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Petition Seeks Warning on Fluoroquinolone Guides

Three people petition FDA to add information from the fluoroquinolone Boxed Warning to the top of the drugs Medication Guide as a way to better inform...

latest-news-card-1
Biologics

BrainStorm Cell Therapy Rejected by Panel

An FDA advisory committee votes 17 to 1 against approving a BrainStorm Cell Therapeutics BLA for NurOwn, an investigational mesenchymal stem cell ther...

latest-news-card-1
Human Drugs

FDA Approves Entyvio Subcutaneous Dosing

FDA approves a subcutaneous administration for Takedas Entyvio (vedolizumab) for maintenance therapy in adults with moderately to severely active ulce...

latest-news-card-1
Federal Register

Biologic Adverse Event Info Collection

Federal Register notice: FDA seeks comments on an information collection extension entitled Adverse Experience Reporting For Licensed Biological Produ...

latest-news-card-1
Federal Register

Drug Application Info Collection Revision

Federal Register notice: FDA seeks comments on an information collection revision entitled Applications for FDA Approval to Market a New Drug 21 CFR ...

latest-news-card-1
Human Drugs

FDA OKs Amicus Pompe Disease Combo Drugs

FDA approves an Amicus Therapeutics NDA for Pombiliti (cipaglucosidase alfa-atga) in combination with Opfolda (miglustat) 65mg capsules for treating a...

latest-news-card-1
Human Drugs

265 Suicidal Reports on GLP-1 Drugs: Reuters

According to Reuters, FDA says it is doing a thorough review of 265 reports of suicidal thoughts or behavior that may be associated with taking Novo N...

latest-news-card-1
Medical Devices

Physiologic Closed-Loop Control Guidance

FDA publishes a guidance on technical considerations for medical devices that use physiologic closed-loop control technology with recommendations for ...

latest-news-card-1

Graft-vs-Host Product Development Guidance

FDA publishes a draft guidance to assist sponsors in developing various types of products to prevent or treat graft-versus-host disease.

latest-news-card-1
Human Drugs

FDA Approves New Depression Drug

FDA approves a Fabre-Kramer Pharmaceuticals NDA for Exxua (gepirone hydrochloride extended-release tablets) for treating major depressive disorder in ...